Form 483

The Estee Lauder Inc Form 483, 2018-01-26

FDA issued a Form 483 to The Estee Lauder Inc on 2018-01-26 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

The Estee Lauder Inc · Melville, United States · Issued January 26, 2018

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

26 Jan 2018
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Jose O Hernandez, Christopher S Fields

26 Jan 2018
21 CFR 211.198(b)(2)

Complaint Investigation/Follow-Up Findings

Cited by Jose O Hernandez, Christopher S Fields

26 Jan 2018
21 CFR 211.42(c)

Defined areas of adequate size for operations

Cited by Jose O Hernandez, Christopher S Fields

26 Jan 2018
21 CFR 211.80(b)

Handling and Storage to Prevent Contamination

Cited by Jose O Hernandez, Christopher S Fields

26 Jan 2018
FDCA 760(b)(1)

Failure of responsible person to report AE (non-RX Drug)

Cited by Jose O Hernandez, Christopher S Fields

Inspected site

TEThe Estee Lauder IncMelville, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.198(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)Cited across public-safe Form 483 observations1x
21 CFR 211.80(b)Cited across public-safe Form 483 observations1x
FDCA 760(b)(1)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere